Synthetech Inc.

• Public
• US

Dow Jones Description

Synthetech is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, SPPS resins and proprietary custom chiral intermediates primarily for the pharmaceutical and cosmeceutical industries. Synthetech's products support the development and manufacture of therapeutic peptides and peptidomimetic small molecule drugs at every stage of a customer's clinical development pipeline; including regulatory starting materials advanced intermediates, and early-phase APIs. Synthetech's domestic and international customer base includes major pharmaceutical and emerging biopharmaceutical companies, as well as contract drug synthesis firms. Synthetech also supplies catalog quantities of specialty amino acids to research institutions, universities and drug discovery firms. The Company's integrated 'grams to tons' production capabilities emphasizes its commitment to customers to be a long-term player from the early phases of pharmaceutical discovery and clinical development through approval, market launch and commercialization. Synthetech's products are used in peptide, peptidomimetic small molecule and other drugs under development or on the market for the treatment of AIDS, cancer, cardiovascular and other diseases. Synthetech's goal is complete customer satisfaction in the cost-effective manufacture and delivery of pharmaceutical fine chemicals...

Number of Employees 75

Contact Information

Peer Companies

• Praxair Inc.
• Air Products & Chemicals Inc.
• Ashland Inc.
• Lubrizol Corp.
• Westlake Chemical Corp.
• All Companies